Research-Studie


Original-Research: dynaCERT Inc - von GBC AG

Einstufung von GBC AG zu dynaCERT Inc

Unternehmen: dynaCERT Inc
ISIN: CA26780A1084

Anlass der Studie: Research Report (Initiation of Coverage)
Empfehlung: BUY
Kursziel: 1.90 CAD
Kursziel auf Sicht von: 31.12.2020
Letzte Ratingänderung: -
Analyst: Julien Desrosiers, Matthias Greiffenberger

'Unique product with no competing technologies in a total market valued at
over USD 6 Trillion. Massive sales revenues expected in the next few years.
Worldwide distribution network established. International orders and MOU
signed. Tested, Certified and Patented technology with high net margin.'

dynaCERT is a leading hydrogen technology company developing carbon
emissions reduction and fuel economy solutions for diesel-powered
combustion engines. The company has proven, proprietary and patented
technologies. Their disruptive solution incorporates emissions reduction,
fuel savings, carbon credit monetizing solutions as well as fleet
management software, all in one product.

The company addresses the needs to reduce NOx, COx and TCH emissions in
order to comply with new-stage V environmental regulations with their
HydraGEN TM line of products. These devices also improve the engine fuel
efficiency, providing clients with a high ROI (return on investment).

The company has established a worldwide sales network and has the potential
to deploy its solutions in Canada, USA, Europe, South America, Mexico,
Middle East and Asia. The company has already sold units to governments and
private companies on three continents.

dynaCERT has overcome critical engineering challenges and now has a
complete line of products that, combined, can reach a total market of USD 6
trillion with no known direct competitor, including but not limited to
industries such as transportation, rail, marine, oil/gas, stationary
generators and mining.

On this basis, we conservatively project the company to have yearly
revenues of over USD 500M within the next seven years with a gross margin
of close to 40%.

The company’s main product, HydraGEN TM, costs between USD 6,200$ and
8,000$ and has an ROI of 9 - 18 months based on their fuel efficiency. The
company has also partnered with a financial institution to offer a monthly
payment solution for HydraGEN TM clients, limiting their capital
expenditure for acquiring and installing dynaCERT products.

The company has just received the ABE certification from Germany. This is a
transformative step in the history of the company as they can now sell
their products in Europe. Furthermore, the certificate is recognized in
Asia, South America and the Middle East. With this crucial step made, we
believe that the company can achieve massive sales in the next few years.
The ABE certification also serves as a strong stamp of approval.

The company has an assembly facility in Toronto, Canada, that can produce
up to 12,000 units a month for a yearly total of 144,000 units. With a
strong adoption rate within the next few years, we project the company to
sell just under a thousand units in 2019, 10,000 in 2020 and over 30,000 by
2021.

Accordingly, we project that the company will post total gross revenues of
USD 4.6 million in 2019 USD 62.4 million in 2020 and USD 223.9 million in
2021.

Based on our DCF valuation, we have calculated a price target of 1.90 CAD
(1.43 USD; 1.30 EUR). Against the background of the high upside potential,
we assign a BUY rating.

Die vollständige Analyse können Sie hier downloaden:
http://www.more-ir.de/d/19029.pdf

Kontakt für Rückfragen
Jörg Grunwald
Vorstand
GBC AG
Halderstraße 27
86150 Augsburg
0821 / 241133 0
research@gbc-ag.de
++++++++++++++++
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG und Art. 20 MAR. Beim oben analysierten Unternehmen ist folgender möglicher Interessenkonflikt gegeben: (5a,5b,11); Einen Katalog möglicher Interessenkonflikte finden Sie unter:
http://www.gbc-ag.de/de/Offenlegung
+++++++++++++++
Date and time of completion of this research: 20/09/2019 (12:00)
Date and time of first distribution: 20/09/2019 (13:00)
Target price valid until: max. 31/12/2020

-------------------übermittelt durch die EQS Group AG.-------------------


Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw.
Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung
oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.

Anleihe im Fokus

„Semper idem Underberg AG: Emission neuer Unternehmensanleihe 2019/2025“

- Emissionsvolumen: bis zu 60 Mio. Euro
- ISIN: DE000A2YPAJ3 / WKN: A2YPAJ
- Stückelung / Mindestanlage: 1.000 Euro - Zinssatz (Kupon): Liegt in einer Spanne von 4,00 % bis 4,25 % p.a.
- Laufzeit: 6 Jahre
- Zinszahlung: jährlich, jeweils am 18. November (nachträglich), erstmals am 18. November 2020
- Rückzahlungskurs: 100%
- Fälligkeit: 18. November 2025
- Listing: Listing im Freiverkehr (Open Market) der Frankfurter Wertpapierbörse vorgesehen

GBC-Fokusbox

Expedeon AG mit attraktiver Produktpipeline

Durch die konsequente Fortsetzung der „Grow, Buy & Build“-Strategie hat die im Bereich der Entwicklung und Vermarktung von DNA-Technologien, Proteomik- und Antikörper-Konjugations-Anwendungen tätige Expedeon AG das Umsatzniveau angehoben und auf operativer Ergebnisebene zugleich den Break-Even nachhaltig überschritten. Für die kommenden Perioden ist der Ausbau der Umsatzerlöse mit den bestehenden Produkten geplant. Darüber hinaus verfügt die Expedeon AG über eine attraktive Produktpipeline mit hohem Umsatzpotenzial. Unser Kursziel liegt bei 3,20 € je Aktie. Das Rating lautet KAUFEN.

News im Fokus

Wirecard AG beauftragt unabhängige Prüfung

21. Oktober 2019, 07:40

Aktuelle Research-Studie

CO.DON AG

Original-Research: CO.DON AG (von Sphene Capital GmbH): Buy

21. Oktober 2019